NewsBenzinga英国医薬品・医療製品規制庁、長鎖脂肪酸酸化障害の成人および小児患者の治療に対するトリヘプタノイン経口液剤を承認 英国医薬品・医療製品規制庁、長鎖脂肪酸酸化障害の成人および小児患者の治療に対するトリヘプタノイン経口液剤を承認 Benzinga 2026.10.30 15:03 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report